These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 6339106

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Calcium antagonists. Some chemical-pharmacologic aspects.
    Triggle DJ, Swamy VC.
    Circ Res; 1983 Feb; 52(2 Pt 2):I17-28. PubMed ID: 6299605
    [Abstract] [Full Text] [Related]

  • 4. Calcium antagonism: a new approach.
    Nayler WG.
    Clin Exp Pharmacol Physiol Suppl; 1982 Feb; 6():3-13. PubMed ID: 6288293
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [The calcium-antagonistic fundamental effects of Verapamil on myocardial fibers and smooth muscle cells of the blood vessels].
    Fleckenstein A, Grün G, Byon KY.
    Minerva Med; 1975 May 23; 66(38):1827-37. PubMed ID: 1128823
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Experimental vasoprotection by calcium antagonists against calcium-mediated arteriosclerotic alterations.
    Fleckenstein-Grün G, Thimm F, Czirfuzs A, Matyas S, Frey M.
    J Cardiovasc Pharmacol; 1994 May 23; 24 Suppl 2():S75-84. PubMed ID: 7898099
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Influence of Ca++-channel blocking agents on calcium transients and tension development in isolated mammalian heart muscle.
    Morgan JP, Wier WG, Hess P, Blinks JR.
    Circ Res; 1983 Feb 23; 52(2 Pt 2):I47-52. PubMed ID: 6831653
    [Abstract] [Full Text] [Related]

  • 13. Calcium-channel blocking agents.
    Leonard RG, Talbert RL.
    Clin Pharm; 1982 Feb 23; 1(1):17-33. PubMed ID: 6764159
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Calcium antagonists. Mechanisms, therapeutic indications and reservations: a review.
    Opie LH.
    Q J Med; 1984 Feb 23; 53(209):1-16. PubMed ID: 6324268
    [Abstract] [Full Text] [Related]

  • 16. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW, Grupp G, Grupp IL, DiSalvo J, DePover A, Schwartz A.
    Circ Res; 1983 Feb 23; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacological basis for the therapeutic applications of slow-channel blocking drugs.
    Singh BN.
    Angiology; 1982 Aug 23; 33(8):492-515. PubMed ID: 7051905
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.